Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databasesQiaofang Liang, Hailong Li, Xiaolin Liao et al.|Frontiers in Pharmacology|2024Cited by 30
Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databasesQiaofang Liang, Hongwen Wu, Ying He et al.|Expert Opinion on Drug Safety|2024Cited by 8
A Cross-Scale Method of Fabricating Transverse Electrode-Embedded NanoporeHang Liu, Quanjun Liu, Hongwen Wu et al.|Nanoscience and Nanotechnology Letters|2016Cited by 0
Single Nucleotide Discrimination by <I>α</I>-Hemolysin NanoporeHang Liu, Quanjun Liu, Dejian Gu et al.|Nanoscience and Nanotechnology Letters|2016Cited by 0